BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23963148)

  • 41. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
    Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
    J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy.
    Wang HB; Yao H; Li CS; Liang LX; Zhang Y; Chen YX; Fang JY; Xu J
    J Dig Dis; 2017 Oct; 18(10):574-581. PubMed ID: 28851046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.
    Ugai T; Väyrynen JP; Lau MC; Borowsky J; Akimoto N; Väyrynen SA; Zhao M; Zhong R; Haruki K; Dias Costa A; Fujiyoshi K; Arima K; Wu K; Chan AT; Cao Y; Song M; Fuchs CS; Wang M; Lennerz JK; Ng K; Meyerhardt JA; Giannakis M; Nowak JA; Ogino S
    Cancer Immunol Immunother; 2022 Apr; 71(4):933-942. PubMed ID: 34529108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
    Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
    Front Immunol; 2019; 10():2368. PubMed ID: 31681276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
    BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
    Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
    Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effector memory T cells, early metastasis, and survival in colorectal cancer.
    Pagès F; Berger A; Camus M; Sanchez-Cabo F; Costes A; Molidor R; Mlecnik B; Kirilovsky A; Nilsson M; Damotte D; Meatchi T; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Galon J
    N Engl J Med; 2005 Dec; 353(25):2654-66. PubMed ID: 16371631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of intra-tumoral CD8
    Sideras K; Galjart B; Vasaturo A; Pedroza-Gonzalez A; Biermann K; Mancham S; Nigg AL; Hansen BE; Stoop HA; Zhou G; Verhoef C; Sleijfer S; Sprengers D; Kwekkeboom J; Bruno MJ
    J Surg Oncol; 2018 Jul; 118(1):68-76. PubMed ID: 29878369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    Ziai J; Gilbert HN; Foreman O; Eastham-Anderson J; Chu F; Huseni M; Kim JM
    PLoS One; 2018; 13(1):e0190158. PubMed ID: 29320521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.
    Pretscher D; Distel LV; Grabenbauer GG; Wittlinger M; Buettner M; Niedobitek G
    BMC Cancer; 2009 Aug; 9():292. PubMed ID: 19698134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between clinical outcome and CD8
    Kleist B; Bagdonas M; Oommen P; Schoenhardt I; Levermann J; Poetsch M
    Histopathology; 2018 Jan; 72(2):201-215. PubMed ID: 28746988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a Fully Automated Method to Obtain Reproducible Lymphocyte Counts in Patients With Colorectal Cancer.
    Fiehn AK; Reiss B; Gögenur M; Bzorek M; Gögenur I
    Appl Immunohistochem Mol Morphol; 2022 Aug; 30(7):493-500. PubMed ID: 35703148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software.
    Berben L; Wildiers H; Marcelis L; Antoranz A; Bosisio F; Hatse S; Floris G
    Histopathology; 2020 Jul; 77(1):79-91. PubMed ID: 32281132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.
    Green VL; Michno A; Stafford ND; Greenman J
    Cancer Immunol Immunother; 2013 May; 62(5):863-73. PubMed ID: 23359088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
    Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
    J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.